Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry is a dynamic in-person and online event for medicinal and biophysical chemists working in pharma, biotech, and academia. Nearly 800 attendees participated virtually this year, with 71% of delegates from pharma/biotech and 16% from academia. 60% of attendees were scientists/technologists and...
Over the years, we have witnessed unprecedented success, advancement, and investment in biotech R&D. As a result, R&D competition is as fierce as it has ever been. But many companies are only focused on their progress of assets and portfolios and that inward-facing diligence typically does not incorporate a rational, pragmatic, and unbiased view of...
The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 80+ dedicated...
Join Biocom California and the U.S. Commercial Service of the U.S. Department of Commerce for a live webinar about biotech expansion opportunities in Germany and the U.K. The panel will discuss how the CS can assist Bay Area biotechs with resources, USG assistance, and inroads to the German and U.K. markets. Featured speakers from Bay Area-based Gritstone Bio and Invitae will...
How does the current economic environment affect the biotech venture investor mindset and outlook? How should you position your company and cater your pitch for success? Join our expert panel for an informative and eye-opening webinar. Speakers: —Mike Powell, Executive Partner, Omega Funds —Shobha Parthasarathi, Vice President, Xontogeny —Kanad Das, Investment Director, Boehringer Ingelheim Venture...
Cell & Gene therapies are the latest revolution in medicine manufacturing. Unlike small molecules or traditional biotech products, these therapies introduce cells and genes into a patient to treat the underlying cause of a disease—they are living medicines! Whether you are producing biologic drug substance, conducting sterile fill-finish operations, or entering into cell and gene...
Welcome to 2022 Stanford Drug Discovery Symposium. This symposium provides a valuable and important platform for inspiring interdisciplinary exchange at the forefront of drug research and will support a fantastic networking experience. It provides a great resource for researchers, pharmaceutical companies, investment groups, and those in the wider biomedical community interested in discovering new drugs...
BioTrinity 2022: Catalysing Growth in the Life Sciences Industry BioTrinity is a proven, must-attend London conference, that catalyses growth and supports in-person re-engagement across the life sciences industry. The event is attended by an ever-evolving audience of early stage and emerging life sciences R&D Companies, investors, large pharma, and other valued partners throughout the life...
Join us for a two-day event uniting experts on viral safety and viral clearance taking place at the Hyatt Centric Fisherman's Wharf in San Francisco, CA. Gain insight from expert regulatory authorities, academic researchers, and industry leaders who are defining the way we evaluate biologics, vaccines, and advanced therapeutic medicinal products (ATMPs). Discover new technologies,...
Regulatory Pathways Available to Speed Development and Approval Veristat and TOPRA will be hosting a webinar on the topic of: Expediting Access to Novel/Medicinal Products in the United States and Europe Tuesday, April 26, 2022 10:00 AM - 11:00 AM EDT (15:00 -16:00 BST) What You Will Learn Bringing novel medicinal products to market is a long,...
Identifying the key risks to be monitored in a clinical study is critical for a successful implementation of a Risk-Based Quality Management process (RBQM), and even more, to the overall success of the clinical trial. Identifying the right Key Risk Indicators (KRIs) is also of utmost importance because they are the risk indicators that enable...
Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network's networking platform. Connect with life science colleagues from all over the world. BioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life...
